A ketogenic diet supplement could improve CAR T cell function, offering a potential boost to cancer therapy, according to new research.

Ketogenic supplement shows promise as a new approach in cancer treatment, potentially aiding in tumor reduction and improving patient outcomes

Ketogenic supplement shows promise as a new approach in cancer treatment, potentially aiding in tumor reduction and improving patient outcomes

Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo

Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo

Beta-hydroxybutyrate (BHB), a ketogenic diet metabolite, enhances CAR T cell activation, offering a cost-effective boost for cancer immunotherapy.

MONDAY, Dec. 9, 2024 (HealthDay News) -- A component of the keto diet appears to boost the powers of immunotherapy in treating cancer, a new study...

Scientists have developed CCI-38, a compound that targets YTHDF2 to improve CAR T cell therapy and overcome immune evasion in cancer.

A new study led by UCLA Health Jonsson Comprehensive Cancer Center (USA) investigators offers new evidence that dietary changes may help reduce...

The COVID-19 pandemic and recent Nobel Prize recognition have spotlighted mRNA therapies as a promising approach for diseases like cancer. Found in...